Aaron Nudelman

About Aaron Nudelman

I am an experienced patent attorney, scientist, and biotech IP executive with a proven record of building and leading high-performing IP teams, supporting business growth, and creating value through intellectual property.Currently, I serve as SVP, Head of Intellectual Property for ElevateBio and its portfolio companies Life Edit Therapeutics and BaseCamp leading a team focused on protecting and monetizing proprietary technologies. From July 2020 until March 2025, I concurrently served as VP, Head of IP for AlloVir, running all aspects of its IP strategy and portfolio management.My background combines years of IP strategy, patent prosecution, and IP-focused contract negotiation with deep scientific expertise in molecular biology, gene editing, and cell and gene therapies (including T cell- and B cell-based immunotherapies and iPSCs). I work closely with research, clinical, and business / leadership teams to align IP strategy with corporate goals, support strategic growth, and help advance transformative therapies for patients with serious diseases. My experiences make me uniquely well-positioned to optimize and streamline biotech and pharma IP strategy at any stage, having supported diverse business models ranging from Life Edit’s internal and partnered therapeutic and platform technology pipelines, BaseCamp’s GMP manufacturing business, and AlloVir’s clinical product estate.Licensed to practice before the USPTO and in Washington State.My experience includes:• Patent prosecution & IP diligence: 12+ years, including nearly 5 years as Head of IP in-house• Collaboration & licensing: nearly 5 years negotiating in/out-licenses (including with large pharma), MSAs, DMSAs, MTAs, CDAs, and other agreements• Consulting: 1+ year as IP consultant for pharma, 3 years as biotech R&D consultant • Scientific experience/expertise: 10+ years molecular & cellular biology techniques• IP Strategy & team management: Global IP strategy, establishment of IP processes/best practices, IP team management, budgeting, and patent prosecution and IP diligenceScientific expertise includes:• Gene editing/therapy (RNA-guided nucleases, base editors, RT-editors)• Immunotherapies (CAR-T, virus-specific T cells, B cells, iPSCs/iPSC-derived cells)• Cell engineering, protein purification, and LNP/viral delivery• Cancer, virology, immunology, pharmacology• Diagnostics, assay development

Experience

1. Senior Vice President, Head of Intellectual Property

   ElevateBio

   Jul 2022 — Present

Education

• Westmont College

  BS, Biochemistry / Molecular Biology

  1999 — 2003

• University of Washington - School of Medicine

  Ph.D, Pharmacology (Biochemistry / Molecular Biology)

  2003 — 2008

• Seattle University School of Law

  Doctor of Law - JD

  2014 — 2017